Endpoint · evidencePOSTapi.magentlab.com /api/calc/hfa_icos_her2
Lyon 2020 HFA-ICOS baseline cardiovascular risk before HER2-targeted therapy (trastuzumab and related agents).
Read more
Lyon 2020 HFA-ICOS baseline cardiovascular risk before HER2-targeted therapy (trastuzumab and related agents). Very high, high, medium, or low from published factors plus Medium 1/2 points; expert-opinion cardiotoxicity guide <2% / 2-9% / 10-19% / >=20%. Concurrent anthracycline is High; sequential anthracycline before HER2 is Medium 1. Deterministic published classification with citation; not a treatment order. magent does not measure LVEF or biomarkers.Overview
Grade?
UNRATED
0 of 30 paid calls toward a letter
Price
$0.005 per call
Paid calls
none yet
delivery unknown until someone pays
More info
Seller?
URL
https://api.magentlab.com/api/calc/hfa_icos_her2
Seen
first 29 days ago · last 10 hr ago
25 free handshakes
Payment
Pays through
x402
Offered on?
Base USDC
Listed on?
Base
Paid calls
No paid calls yet.
Delivery is unknown until someone pays. A handshake only shows it asks for payment.
Verify it yourself
npx teppi-check https://api.magentlab.com/api/calc/hfa_icos_her2curl -s https://api.teppi.xyz/v1/trust/cap_01M1RD9JSSTC3XXYMM8T8R01RT